Ajanta Pharma Ltd 2025 AR2
The report highlights Ajanta Pharma Limited's financial and sustainability performance for the fiscal year 2024-2025. The company achieved a revenue of ₹4,648 crore, representing a 10% growth, and a profit after tax of ₹920 crore. On the sustainability front, Ajanta expanded its solar power capacity to 12.6 MW, fulfilling 34% of its energy requirements from renewable sources. These green energy initiatives and energy-saving measures successfully reduced carbon dioxide emissions by 14,268 tonnes during the year.
Company: Ajanta Pharma Ltd
Sector: Health Care
Country: India
Year: 2025
Type: AR2
Pages: 137
Ajanta Pharma Ltd
Annual Report
The report highlights Ajanta Pharma Limited's financial and sustainability performance for the fiscal year 2024-2025. The company achieved a revenue of ₹4,648 crore, representing a 10% growth, and a profit after tax of ₹920 crore. On the sustainability front, Ajanta expanded its solar power capacity to 12.6 MW, fulfilling 34% of its energy requirements from renewable sources. These green energy initiatives and energy-saving measures successfully reduced carbon dioxide emissions by 14,268 tonnes during the year.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Apr 1, 2024 - Mar 31, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees